Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sana Biotechnology, Inc. - Common Stock (NQ:SANA)

1.498 -0.182 (-10.86%)
Streaming Delayed Price Updated: 2:44 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,558,526
Open 1.650
Bid (Size) 1.490 (57)
Ask (Size) 1.500 (71)
Prev. Close 1.680
Today's Range 1.490 - 1.670
52wk Range 1.520 - 10.50
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Mineralys, Sana, Aeon: These 3 Biotech Stocks Saw The Sharpest Retail Interest Spike In Q1
Three small-cap stocks have intrigued Stocktwits users the most among the biotech sector this year, thanks to promising data from clinical trials and a leadership shuffle. 
Via Stocktwits
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
-9.2%
-9.2%
1 Month
-38.4%
-38.4%
3 Month
-7.0%
-7.0%
6 Month
-64.0%
-64.0%
1 Year
-85.2%
-85.2%

More News

Read More
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Top 2 Health Care Stocks That Are Ticking Portfolio Bombs
Via Benzinga
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology
From Faruqi & Faruqi LLP
Via GlobeNewswire
Sana Biotechnology, Inc. Stockholder News: Robbins LLP Reminds Investors of the Class Action Lawsuit Against SANA
From Robbins LLP
Via GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SANA
From The Rosen Law Firm PA
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Sana Biotechnology, Inc. and Certain Officers – SANA
From Pomerantz LLP
Via GlobeNewswire
Rosen Law Firm Urges Sana Biotechnology, Inc. (NASDAQ: SANA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
From Sana Biotechnology, Inc
Via GlobeNewswire
Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference
From Sana Biotechnology, Inc
Via GlobeNewswire
Retail Traders Flocked To These 5 Biotech Stocks In January — Here’s Why
Via Stocktwits
There May Still Be Time to Get in on These 3 Trending Biotechs
Via MarketBeat
Topics ETFs Economy
Exposures Economy Interest Rates
Biotech Breakthroughs: Sana Biotechnology (NASDAQ: SANA) Type 1 Diabetes, CS Diagnostics (OTCQB: CSDX) Cancer Therapy – CURR, TPET, PRSO, PNPN.V, EONR – Plus More Stocks Under $2 Inside See Now!
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Sana Biotechnology, Inc
Via GlobeNewswire
Crude Oil Down 1%; US Weekly Jobless Claims Decline
Via Benzinga
Exposures Fossil Fuels
AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
US Stocks Down; Acuity Brands Posts Weak Revenue
Via Benzinga
Sana Biotechnology Stock Surges Over 200% On Wednesday - Here's Why
Via Benzinga
Why Cal-Maine Foods Shares Are Trading Higher By 4%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
From Sana Biotechnology, Inc
Via GlobeNewswire
Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus Erythematosus
From Sana Biotechnology, Inc
Via GlobeNewswire
Sana Biotechnology to Present at December 2024 Investor Conferences
From Sana Biotechnology, Inc
Via GlobeNewswire

Frequently Asked Questions

Is Sana Biotechnology, Inc. - Common Stock publicly traded?
Yes, Sana Biotechnology, Inc. - Common Stock is publicly traded.
What exchange does Sana Biotechnology, Inc. - Common Stock trade on?
Sana Biotechnology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sana Biotechnology, Inc. - Common Stock?
The ticker symbol for Sana Biotechnology, Inc. - Common Stock is SANA on the Nasdaq Stock Market
What is the current price of Sana Biotechnology, Inc. - Common Stock?
The current price of Sana Biotechnology, Inc. - Common Stock is 1.498
When was Sana Biotechnology, Inc. - Common Stock last traded?
The last trade of Sana Biotechnology, Inc. - Common Stock was at 04/01/25 02:44 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.